Table 1

Summary of characteristics of women with breast cancer having and not having immunohistochemistry (IHC) assays performed, Sulaimaniyah, Iraq (2008–2010)
Characteristic IHC assays not performed IHC assays performed P value*
No. % No. %
Patients (total = 824) 392 47.6 432 52.4
Age
20-49 216 55.1 261 60.4 0.26
50-59 100 25.5 102 23.6
≥ 60 76 19.4 69 16.0
Mean (range) 49.5 ± 12.0 (23–88) 47.8 ± 11.5 (21–83) 0.03
Ethnicity/residence
Kurd/Sulaimaniyah 241 61.4 265 61.3 0.12
Kurd/not-Sulaimaniyah 91 23.2 117 27.1
Arab/not-Sulaimaniyah 63 16.0 50 11.6
Tumor stage
1 36 9.2 37 8.6 0.97
2 121 30.9 136 31.5
3 104 26.5 115 26.6
4 28 7.1 28 6.5
Unknown 103 26.3 116 26.9

* Comparing the distribution of IHC tested and non-tested patients by age, ethnicity/residence, and tumor stage (X2 tests). The difference in the ages of IHC tested and non-tested subjects was compared by a K-S test for normality and equal distribution and a t-test.

Majid et al.

Majid et al. BMC Women's Health 2012 12:16   doi:10.1186/1472-6874-12-16

Open Data